A detailed history of Prudential Financial Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 518,533 shares of ADMA stock, worth $10.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
518,533
Previous 395,574 31.08%
Holding current value
$10.5 Million
Previous $4.42 Million 134.4%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$11.21 - $20.03 $1.38 Million - $2.46 Million
122,959 Added 31.08%
518,533 $10.4 Million
Q2 2024

Aug 13, 2024

BUY
$5.98 - $11.18 $2.15 Million - $4.02 Million
359,238 Added 988.66%
395,574 $4.42 Million
Q1 2024

May 14, 2024

BUY
$4.4 - $6.74 $100,082 - $153,308
22,746 Added 167.37%
36,336 $239,000
Q4 2023

Feb 13, 2024

BUY
$3.08 - $4.52 $1,694 - $2,485
550 Added 4.22%
13,590 $61,000
Q2 2023

Aug 11, 2023

BUY
$3.12 - $4.22 $3,057 - $4,135
980 Added 8.13%
13,040 $48,000
Q1 2023

May 12, 2023

BUY
$3.01 - $3.87 $933 - $1,199
310 Added 2.64%
12,060 $39,000
Q4 2022

Feb 14, 2023

SELL
$2.47 - $3.88 $9,139 - $14,356
-3,700 Reduced 23.95%
11,750 $0
Q3 2022

Nov 04, 2022

SELL
$2.03 - $2.86 $34,916 - $49,192
-17,200 Reduced 52.68%
15,450 $38,000
Q2 2022

Aug 15, 2022

BUY
$1.43 - $2.2 $46,689 - $71,830
32,650 New
32,650 $65,000
Q2 2021

Aug 16, 2021

SELL
$1.51 - $2.07 $19,492 - $26,721
-12,909 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$1.67 - $2.95 $3,306 - $5,841
1,980 Added 18.12%
12,909 $23,000
Q3 2020

Nov 16, 2020

BUY
$2.04 - $3.74 $22,295 - $40,874
10,929 New
10,929 $26,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.97B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.